Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

1818MO Development and validation of a predictive model of aromatase inhibitor musculoskeletal toxicity (AIMT) among patients (pts) with early breast cancer (EBC).

Autor: Lapidari, P.¹ (AUTHOR), Lustberg, M.² (AUTHOR), Havas, J.¹ (AUTHOR), Pagliuca, M.³ (AUTHOR), Bousrih, C.⁴ (AUTHOR), Jouannaud, C.⁵ (AUTHOR), Fournier, M.⁶ (AUTHOR), Jacot, W.⁷ (AUTHOR), Vanlemmens, L.⁸ (AUTHOR), Kaderbhai, C.⁹ (AUTHOR), Tredan, O.¹⁰ (AUTHOR), Levy, C.¹¹ (AUTHOR), Martin, A-L.¹² (AUTHOR), Gaudin, C.¹³ (AUTHOR), Menvielle, G.¹ (AUTHOR), Franzoi, M.A.¹⁴ (AUTHOR), Vaz Luis, I.V.¹⁵ (AUTHOR), Di Meglio, A.¹⁶ (AUTHOR)

Publikováno v: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS1078-S1079. 2p.

A Randomized Trial of Hypofractionated Post-Mastectomy Radiation Therapy (PMRT) in Women with Breast Reconstruction (RT CHARM, Alliance A221505)

Autor: Poppe, M.M., Le-Rademacher, J., Haffty, B.G., Jr, Hansen, E.K., Agarwal, J., Wagner, J., Kong, I., Armer, J., Arthur, D.W., Whelan, T.J., Lee, M.K., Kour, O., Lustberg, M., Partridge, A., Carey, L.A., Ruddy, K.J., Gaffney, D.K., Stecklein, S.R., Bernstein, M.B., Khan, A.J.

Publikováno v: In International Journal of Radiation Oncology, Biology, Physics 1 October 2024 120(2) Supplement:S11-S11

342MO Metastatic hormone receptor-positive breast cancer outcomes in 628 patients with BRCA1, BRCA2, or PALB2 pathogenic variants: Real-world data analysis of genomics and targeted therapy sequencing

Autor: Parkinson, G., Lustberg, M., Nazari, S., Elliott, A., Sledge, G., Jeselsohn, R., Hsu, E., Sobol, R.W., Sandoval-Leon, A., Gopalakrishnan, R., Makhoul, I., Nye, L.E., Kurian, A., Lynce, F., Graff, S.

Publikováno v: In Annals of Oncology September 2024 35 Supplement 2:S358-S358

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.